Expression of COX-2, IL-1β, TNF-α and IL-4 in epithelium of serrated adenoma, adenoma and hyperplastic polyp

Archives of Medical Science

Volumn 12, Issue 1, 2016, Pages 172-178

  Szylberg, Łukasz ^a   Janiczek, Marlena ^a   Popiel, Aneta ^a   Marszałek, Andrzej ^a,b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Inflammatory cytokines; Polyps

Indexed keywords

CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; INTERLEUKIN 4; PROTEIN ANTIBODY; TUMOR NECROSIS FACTOR;

ADENOMA; ADULT; AGED; ARTICLE; CELLULAR DISTRIBUTION; COLON EPITHELIUM; COLON POLYP; CONTROLLED STUDY; DISEASE CLASSIFICATION; EPITHELIUM CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASTIC POLYP; MAJOR CLINICAL STUDY; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SERRATED ADENOMA;

EID: 85010338992     PISSN: 17341922     EISSN: 18969151     Source Type: Journal    
DOI: 10.5114/aoms.2016.57594     Document Type: Article

References (33)

1. Watson AR, Jankowski J. Hyperplastic polyps, serrated adenomas, and the serrated polyp neoplasia pathway. Curr Colorectal Cancer Rep 2007;3:3-9.
2. Klimczak A, Kempińska-Mirosławska B, Mik M, et al. Colorectal cancer mortality in Poland - analysis of regional variation. Arch Med Sci 2014;10:63-7.
3. Ciria JP, Eguiguren M, Cafiero S, et al. Could preoperative short-course radiotherapy be the treatment of choice for localized advanced rectal carcinoma? Rep Pract Oncol Radiother 2014;20:1-11.
4. Hamilton SR, Vogelstein B, Kudo S. Carcinoma of the colon and rectum. Pathology and Genetics of Tumours of the Digestive System. WHO Classification of Tumours 2000;2:105-19.
5. Teoh HH, Delahunt B, Isbister WH. Dysplastic and malignant areas in hyperplastic polyps of the large intestine. Pathology 1989;21:138-42.
6. Jass JR, Iino H, Ruszkiewicz A, et al. Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut 2000;47:43-9.
7. Liljegren A, Lindblom A, Rotstein S, Nilsson B, Rubio C, Jaramillo E. Prevalence and incidence of hyperplastic polyps and adenomas in familial colorectal cancer: correlation between the two types of colon polyps. Gut 2003;52:1140-7.
8. Leggett BA, Devereaux B, Biden K, Searle J, Young J, Jass J. Hyperplastic polyposis: association with colorectal cancer. Am J Surg Pathol 2001;25:177-84.
9. Bauer VP, Papaconstantinou HT. Management of serrated adenomas and hyperplastic polyps. Clin Colon Rectal Surg 2008;21:273-9.
10. Lash RH, Genta RM, Schuler CM. Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J Clin Pathol 2010;63:681-6.
11. Torlakovic E, Skovlund E, Snover DC, Torlakovic G, Nesland JM. Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 2003;27:65-81.
12. Longacre TA, Fenoglio-Preiser CM. Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol 1990;14:524-37.
13. Balbinotti RA, Ribeiro U Jr, Sakai P, et al. hMLH1, hMSH2 and cyclooxygenase-2 (Cox-2) in sporadic colorectal polyps. Anticancer Res 2007;27:4465-72.
14. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539-45.
15. Morrison WB. Inflammation and cancer: a comparative view. J Vet Intern Med 2012;26:18-31.
16. Goswami B, Rajappa M, Sharma M, et al. Inflammation: its role and interplay in the development of cancer, with special focus on gynecological malignancies. Int J Gynecol Cancer 2008;18:591-9.
17. Coussens LM, Werb Z. Inflammation and cancer. Nature 2012;420:860-7.
18. Wiiliam CS, Mann M, Dubois RN. The role of cycloxygenases in inflammation, cancer and development. Oncogene 1999;18:7906-16.
19. Leek RD, Landers R, Fox SB, Ng F, Hartis AL, Lewis CE. Association of tumour necrosis factor and its receptor with thymidine phosphorylase expression in invasive breast carcinoma. Br J Cancer 1998;77:2246-51.
20. Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005;7:211-7.
21. Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006;313:1960-4.
22. Szylberg L, Janiczek M, Popiel A, et al. Large bowel genetic background and inflammatory processes in carcinogenesis: systematic review. Adv Clin Exp Med 2015;4:555-63.
23. Lamont EB, Dias LE, Lauderdale DS. NSAIDs and colorectal cancer risk: do administrative data support a chemopreventive effect? J Gen Intern Med 2007;22:1166-71.
24. Brown JR, DuBois RN. COX-2: a molecular target for colorectal cancer prevention. J Clin Oncol 2005;23:2840-55.
25. Liu W, Reinmuth N, Stoeltzing O, et al. Cyclooxygenase-2 is up-regulated by interleukin-1beta in human colorectal cancer cells via multiple signaling pathways. Cancer Res 2003;63:3632-6.
26. Din FV, Theodoratou E, Farrington SM, et al. Effect of aspirin and NSAIDs on risk and survival from colorectal cancer. Gut 2010;59:1670-9.
27. Carson JL, Strom BL, Soper KA, West SL, Morse ML. The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med 1987;147:85-8.
28. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: a meta-analysis. Ann Intern Med 1991;115:787-96.
29. Kawasaki T, Nosho K, Ohnishi M, et al. Cyclooxygenase-2 overexpression is common in serrated and non-serrated colorectal adenoma, but uncommon in hyperplastic polyp and sessile serrated polyp/adenoma. BMC Cancer 2008;8:33.
30. Asting AG, Carén H, Andersson M, Lönnroth C, Lagerstedt K, Lundholm K. COX-2 gene expression in colon cancer tissue related to regulating factors and promotor methylation status. BMC Cancer 2011;11:238.
31. Kiedrowski M, Mroz A, Kaminski M, et al. Predictive factors of proximal advanced neoplasia in the large bowel. Arch Med Sci 2014;10:484-9.
32. Maihöfner C, Charalambous MP, Bhambra U, Lightfoot T, Geisslinger G, Gooderham NJ. Expression of cyclooxygenase-2 parallels expression of interleukin-1beta, interleukin-6 and NF-kappaB in human colorectal cancer. Carcinogenesis 2003;24:665-71.
33. Kanai T, Watanabe M, Hayashi A, et al. Regulatory effect of interleukin-4 and interleukin-13 on colon cancer cell adhesion. Br J Cancer 2000;82:1717-23.